MAPK3 and lung cancer: HC may inhibit PI3K/Akt/mTOR and ERK1/2 signaling pathways in human lung cancer cells [53], while IL17A can inhibit PI3K/Akt/mTOR-mediated autophagy, which causes lung inflammation and fibrosis [54].